Annual CFF
$4.51 M
+$5.95 M+411.69%
31 December 2023
Summary:
Humacyte annual cash flow from financing activities is currently $4.51 million, with the most recent change of +$5.95 million (+411.69%) on 31 December 2023. During the last 3 years, it has risen by +$2.46 million (+119.64%). HUMA annual CFF is now -98.31% below its all-time high of $266.98 million, reached on 31 December 2021.HUMA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$849.00 K
+$1.32 M+281.80%
30 September 2024
Summary:
Humacyte quarterly cash flow from financing activities is currently $849.00 thousand, with the most recent change of +$1.32 million (+281.80%) on 30 September 2024. Over the past year, it has increased by +$1.61 million (+211.13%). HUMA quarterly CFF is now -99.65% below its all-time high of $242.08 million, reached on 30 September 2021.HUMA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$62.84 M
+$1.61 M+2.63%
30 September 2024
Summary:
Humacyte TTM cash flow from financing activities is currently $62.84 million, with the most recent change of +$1.61 million (+2.63%) on 30 September 2024. Over the past year, it has increased by +$58.21 million (+1257.28%). HUMA TTM CFF is now -76.46% below its all-time high of $266.98 million, reached on 31 December 2021.HUMA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUMA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +411.7% | +211.1% | +1257.3% |
| 3 y3 years | +119.6% | -99.7% | -75.9% |
| 5 y5 years | - | - | - |
HUMA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.3% | +411.7% | -99.7% | +211.1% | -76.5% | +4445.9% |
| 5 y | 5 years | -98.3% | +411.7% | -99.7% | +192.7% | -76.5% | +4445.9% |
| alltime | all time | -98.3% | +411.7% | -99.7% | +192.7% | -76.5% | +4445.9% |
Humacyte Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $849.00 K(-281.8%) | $62.84 M(+2.6%) |
| June 2024 | - | -$467.00 K(-100.7%) | $61.23 M(-9.6%) |
| Mar 2024 | - | $62.80 M(<-9900.0%) | $67.71 M(+1402.4%) |
| Dec 2023 | $4.51 M(-411.7%) | -$335.00 K(-56.2%) | $4.51 M(-2.7%) |
| Sept 2023 | - | -$764.00 K(-112.7%) | $4.63 M(-9.3%) |
| June 2023 | - | $6.01 M(-1570.7%) | $5.11 M(-466.2%) |
| Mar 2023 | - | -$409.00 K(+92.9%) | -$1.39 M(-3.6%) |
| Dec 2022 | -$1.45 M | -$212.00 K(-26.6%) | -$1.45 M(-127.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$289.00 K(-40.3%) | $5.31 M(-97.9%) |
| June 2022 | - | -$484.00 K(+5.0%) | $247.68 M(+0.2%) |
| Mar 2022 | - | -$461.00 K(-107.0%) | $247.25 M(-7.4%) |
| Dec 2021 | $266.98 M(>+9900.0%) | $6.55 M(-97.3%) | $266.98 M(+2.5%) |
| Sept 2021 | - | $242.08 M(<-9900.0%) | $260.44 M(+1318.9%) |
| June 2021 | - | -$916.00 K(-104.8%) | $18.36 M(-4.8%) |
| Mar 2021 | - | $19.27 M | $19.27 M |
| Dec 2020 | $2.05 M | - | - |
FAQ
- What is Humacyte annual cash flow from financing activities?
- What is the all time high annual CFF for Humacyte?
- What is Humacyte annual CFF year-on-year change?
- What is Humacyte quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Humacyte?
- What is Humacyte quarterly CFF year-on-year change?
- What is Humacyte TTM cash flow from financing activities?
- What is the all time high TTM CFF for Humacyte?
- What is Humacyte TTM CFF year-on-year change?
What is Humacyte annual cash flow from financing activities?
The current annual CFF of HUMA is $4.51 M
What is the all time high annual CFF for Humacyte?
Humacyte all-time high annual cash flow from financing activities is $266.98 M
What is Humacyte annual CFF year-on-year change?
Over the past year, HUMA annual cash flow from financing activities has changed by +$5.95 M (+411.69%)
What is Humacyte quarterly cash flow from financing activities?
The current quarterly CFF of HUMA is $849.00 K
What is the all time high quarterly CFF for Humacyte?
Humacyte all-time high quarterly cash flow from financing activities is $242.08 M
What is Humacyte quarterly CFF year-on-year change?
Over the past year, HUMA quarterly cash flow from financing activities has changed by +$1.61 M (+211.13%)
What is Humacyte TTM cash flow from financing activities?
The current TTM CFF of HUMA is $62.84 M
What is the all time high TTM CFF for Humacyte?
Humacyte all-time high TTM cash flow from financing activities is $266.98 M
What is Humacyte TTM CFF year-on-year change?
Over the past year, HUMA TTM cash flow from financing activities has changed by +$58.21 M (+1257.28%)